bit.bio Email Format
Biotechnology ResearchEngland, United Kingdom51-200 Employees
bit.bio is a biotechnology company based in Babraham, England, operating in the field of human cell programming for research and therapeutic applications. The company has built an end-to-end platform that enables the creation of any human cell type by directing induced pluripotent stem cells toward a defined identity, delivering high consistency at scale and at a faster rate than traditional methods. Its io Cells product line supplies researchers with well-characterized, scalable human cells to speed up drug discovery while reducing experimental variability. Beyond research products, bit.bio is pursuing a pipeline of txCells for cell therapies and collaborates with partners to map transcription factor–driven cell identity. In June 2026 the company appointed Dr Emma Pepperell as Chief Executive Officer.